xi Rituximab Offers No Extra Benefit to Induction Chemo in ALL By www.medscape.com Published On :: Fri, 8 May 2020 13:26:38 EDT Patients with B-precursor acute lymphoblastic lymphoma may not benefit from adding rituximab to standard induction chemotherapy, suggests UK trial data that also identified novel genetic risk factors. Medscape News UK Full Article Hematology-Oncology News
xi Mayor fears community left out of decision on toxic West Gate Tunnel soil By www.abc.net.au Published On :: Sat, 09 May 2020 12:40:15 +1000 Moorabool Shire Mayor David Edwards says he fears his council is being shut out of any decisions around the dumping of contaminated soil from the West Gate Tunnel project. Full Article Community and Society Mining (Rural) Government and Politics Regional Land Pollution Water Pollution
xi Xi and Trump: insecure 'strongmen' who had nothing to offer in a crisis but vanity By www.theage.com.au Published On :: Mon, 20 Apr 2020 22:09:02 GMT Neither emerges from their handling of the pandemic with any honour. Full Article
xi Xiaomi Just Launched The MiBox 4K That Converts Any TV Into A Smart TV With Awesome Specs By www.mensxp.com Published On :: Fri, 08 May 2020 13:13:01 +0530 Full Article News
xi Xiaomi's New Mi 10 5G Is Here To Take On Flagship Phones & Here's Everything To Know About It By www.mensxp.com Published On :: Fri, 08 May 2020 13:24:11 +0530 Full Article Smartphones
xi Anxious about COVID-19 and returning to work? Here's what you need to know By www.cbc.ca Published On :: Wed, 6 May 2020 04:00:00 EDT With more businesses reopening, some employees are anxious about going back to work, worried their health could be at risk and wondering if they have any rights not to return. Here's what you need to know about your employment obligations if you are called back to work and any recourse you may have. Full Article News/Business
xi Galaxies collide in stunning picture By www.news.com.au Published On :: Wed, 11 Jan 2017 09:33:00 GMT A NEW image captured by NASA Hubble space telescope shows ‘doomed duo’ galaxies colliding and then trying to destroy one another. Full Article
xi Bellamy’s chief exits after $500m share wipe-out By www.news.com.au Published On :: Wed, 11 Jan 2017 03:40:00 GMT THE chief executive of troubled baby formula maker Bellamy’s is stepping down in the wake of its disastrous share price plunge. Full Article
xi Water supplies switched off over RAAF toxin fears By www.adelaidenow.com.au Published On :: Mon, 20 Jun 2016 12:20:00 GMT TWO aquifers that supply water to market gardeners, businesses and parks in Adelaide’s north have been temporarily shut down in response to concerns over possible groundwater contamination in the area. Full Article
xi PL's all-time Argentine XI after Angel Di Maria saga including two Man Utd stars By www.mirror.co.uk Published On :: Sat, 9 May 2020 13:00:00 +0000 In the wake of Di Maria's wife's explosive rant against the city of Manchester and Gary Neville's response, Mirror Sport has assembled the ultimate Argentinian Premier League XI Full Article Sport
xi Crise sanitaire: anxiété et symptômes dépressifs chez la moitié des jeunes adultes canadiens By www.journaldemontreal.com Published On :: Thu, 30 Apr 2020 15:53:54 EDT La moitié des jeunes adultes vivent une anxiété profonde et présentent des symptômes de dépression depuis le début de la crise sanitaire. Full Article
xi Brutal race attack on taxi driver By www.themercury.com.au Published On :: Mon, 20 Jun 2016 14:00:00 GMT HOBART taxi driver Mikahil Ahmed is reeling from a brutal racial attack that left him hospitalised and badly damaged his cab. Full Article
xi Queensland mum, 41, wins second national kickboxing title By www.abc.net.au Published On :: Tue, 24 Mar 2020 06:58:45 +1100 Eight years ago Simone Offord took up kickboxing for mental health and exercise. Now the mother of three has claimed her second Australian title. Full Article Sport Boxing Martial Arts Mixed Martial Arts Coaching Women Human Interest
xi Boxing sisters face diabetes fight to pursue sporting dream By www.abc.net.au Published On :: Sat, 28 Mar 2020 08:18:34 +1100 Tamieka and Teya Garcia are making inroads in the boxing industry despite a life-threatening health condition that complicates their efforts to step inside the ring. Full Article Boxing Sport Diabetes Family Community and Society Diseases and Disorders Health People
xi Five men in their 20s charged with esports match fixing By www.abc.net.au Published On :: Sun, 03 May 2020 12:24:04 +1000 Five men are charged with match fixing offences — some of which carry penalties of up to 10 years in jail — as part of the first Australian criminal investigation into esports. Full Article Police Law Crime and Justice Crime Other Sports Sport Games
xi Coronavirus chokes the drug trade — from Wuhan, through Mexico and onto U.S. streets By www.latimes.com Published On :: Fri, 24 Apr 2020 06:00:28 -0400 The coronavirus pandemic has disrupted many industries, both legal and illicit. Production of fentanyl, which relies on chemical ingredients sourced mainly from Wuhan, China, has been particularly hard hit. Full Article
xi The U.S. is pushing Mexico to reopen factories even as workers die of COVID-19 By www.latimes.com Published On :: Thu, 30 Apr 2020 22:32:13 -0400 The United States wants Mexico to reopen its border factories, even as the coronavirus spreads and worker deaths rise. Full Article
xi Mexico's fragile health system running out of room for coronavirus patients By www.latimes.com Published On :: Mon, 4 May 2020 23:38:49 -0400 The coronavirus pandemic is threatening Mexico's fragile public health infrastructure. Full Article
xi Intertronics launches device capable of mixing two-part materials By www.medicalplasticsnews.com Published On :: Wed, 22 Apr 2020 15:19:30 -0000 Adhesives specialist Intertronics has launched the preeflow eco-DUOMIX, a system that mixes and dispenses two-part materials. Full Article
xi US OK's AZ' Farxiga for heart failure with reduced ejection fraction By www.pharmatimes.com Published On :: Wed, 06 May 2020 12:13:58 +0100 Farxiga is the first sodium glucose co-transporter 2 inhibitor cleared by the FDA to treat heart failure with reduced ejection fraction Full Article
xi Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs By xconomy.com Published On :: Mon, 04 May 2020 20:44:46 +0000 The genetic mutations that cause epilepsy don’t stop there. Praxis Precision Medicines CEO Marcio Souza says research also links these genes to other neurological conditions. The biotech startup is turning that research into new neuro drugs and it’s coming out of stealth to share details about its science and its pipeline, which already has two […] Full Article Boston Boston blog main Boston top stories National blog main National top stories New York blog main New York top stories antisense oligonucleotide benzodiazepines Biogen Biotech Blackstone Group Blackstone Life Sciences clinical trials Columbia University David Goldstein Depression Epi4K epilepsy Essential Tremor investing Kiran Reddy Life Sciences Major Depressive Disorder Marcio Souza perimenopausal depression Praxis Precision Medicines PTC Therapeutics startups Steven Petrou Third Rock Ventures University of Melbourne Venture Capital
xi Alexion Pharma Boosts Blood Drug Lineup With $1.4B Deal for Portola By xconomy.com Published On :: Tue, 05 May 2020 18:18:24 +0000 Alexion Pharmaceuticals has agreed to buy Portola Pharmaceuticals in a $1.4 billion deal that brings it a first-in-class therapy for treating life-threatening bleeding. According to financial terms announced Tuesday, Boston-based Alexion (NASDAQ: ALXN) will pay $18 for each outstanding share of Portola (NASDAQ: PTLA). That price is a a nearly 132 percent premium to Monday’s […] Full Article Boston Boston top stories Europe blog main National blog main National top stories San Francisco blog main San Francisco top stories Alexion Pharmaceuticals andexanet alfa Ardhana Sarin Betrixaban Biotech Bristol-myers Squibb clinical trials deals eculizumab FDA Geoffrey Porges Life Sciences Ludwig Hantson paroxysmal nocturnal hemoglobinuria Pfizer Portola Pharmaceuticals Ravulizumab SVB Leerink
xi Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More By xconomy.com Published On :: Fri, 08 May 2020 14:33:23 +0000 Alexion Pharmaceuticals CEO Ludwig Hantson has made no secret that he wants to diversify his company’s drug portfolio and he has shown willingness to open the corporate checkbook to accomplish that goal. Last October, Alexion (NASDAQ: ALXN) struck a $930 million deal to acquire Achillion Pharmaceuticals, a biotech whose lead drug complements the Boston company’s […] Full Article Boston blog main Boston top stories Boulder/Denver blog main Boulder/Denver top stories Detroit blog main Detroit top stories Europe blog main Europe top stories Indiana blog main Indiana top stories National National blog main National top stories New York blog main New York top stories Raleigh-Durham blog main Raleigh-Durham top stories San Diego blog main San Diego top stories San Francisco blog main San Francisco top stories Seattle blog main Seattle top stories Texas blog main Texas top stories Wisconsin blog main Wisconsin top stories AbbVie Achillion Pharmaceuticals Akcea Therapeutics Alexion Pharmaceuticals Alnylam Pharmaceuticals andexanet alfa Antibe Therapeutics Apotex Arrowhead Pharmaceuticals AstraZeneca Avrobio Axcella Health. Newron Pharmaceuticals basal cell carcinoma BioMarin Pharmaceutical BioNtech Biotech blastic plasmacytoid dendritic cell neoplasm Bristol-myers Squibb Bruce Given cancer Cardiff Oncology Carla Poulson Celgene Cell Therapy cemiplimab Censa Pharmaceuticals Chemotherapy chlorambucil Chronic Lymphocytic Leukemia Clarametyx Biosciences Clostridium difficile COVID-19 CRISPR dapagliflozin Diagnostics DiNAQOR dry eye disease epilepsy Federal Trade Commission Ferring Pharmaceuticals FogPharma Fragile X Syndrome Gemini Therapeutics Gene Therapy Gilead Sciences Grail Incyte Innate Immune System investing Joseph Stauffer Kala Pharmaceuticals Kezar Life Sciences Kura Oncology Life Sciences lisocaptagene maraleucel Ludwig Hantson Magenta Therapeutics Marc Uknis Mark Erlander Menarini Group Microbiome microbiome drugs Myonexus Therapeutics Neurological Diseases Noreen Roth Henig Novartis Obinutuzumab Ovid Therapeutics Pfizer Portola Pharmaceuticals pravastatin Praxis Precision Medicines PTC Therapeutics rare disease drugs rebiotix Regeneron Pharmaceuticals remdesirvir Rett syndrome Sanofi Sarepta Therapeutics sarizotan Sherlock Biosciences startups Stemline Therapeutics systolic heart failure TG Therapeutics Tony Gibney TrovaGene U.S. Department of Justice ublituximab umbralisib Ventus Therapeutics Vir Biotechnology
xi People Don't Have to Succumb to Anxiety during This Pandemic By blogs.scientificamerican.com Published On :: Wed, 06 May 2020 16:00:00 GMT That emotion is natural in a situation like this, but there are ways to mitigate it -- Read more on ScientificAmerican.com Full Article Health Behavior & Society
xi British MP Benn talks Brexit challenges and the future of UK clinical research industry By www.acrohealth.org Published On :: Wed, 18 Apr 2018 15:32:25 +0000 The Association of Clinical Research Organizations (ACRO) highlights contributions to health and economy (Leeds, UK) – Facing unprecedented challenges associated with Brexit,... Full Article News Press Releases Brexit MP UK
xi ACRO members talk UK competitiveness and enabling post-Brexit success By www.acrohealth.org Published On :: Thu, 19 Jul 2018 03:14:35 +0000 What happens to clinical research when the UK leaves the EU’s common market and regulatory structure? When public perceptions seem locked onto... Full Article News Brexit UK
xi UK Government focus on strengthening clinical research amidst unique challenges of Brexit By www.acrohealth.org Published On :: Wed, 28 Nov 2018 21:19:02 +0000 The Association of Clinical Research Organizations (ACRO) convenes discussion series that seeks to advance an industry with important health and economic impacts... Full Article News Press Releases Brexit policy UK
xi EU approval for Novartis' Cosentyx in active non-radiographic axial spondyloarthritis By www.pharmafile.com Published On :: Wed, 29 Apr 2020 09:28:04 +0000 Novartis has revealed that the European Commission has moved to approve Cosentyx (secukinumab) for the treatment of active non-radiographic axial spondyloarthritis (nr-axSpA) in adult patients. Full Article axial spondyloarthritis Cosentyx EU Novartis pharma Research and Development Sales and Marketing
xi Portola Pharmaceuticals to merge with Alexion in $1.41bn cash deal By www.pharmafile.com Published On :: Wed, 06 May 2020 10:36:40 +0000 Alexion has announced it is to acquire Boston-based blood disorder specialist Portola Pharmaceuticals in a transaction to the value of $1.41 billion in cash. Full Article Alexion pharma Portola Pharmaceuticals Research and Development Sales and Marketing
xi AZ's Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction By www.pharmafile.com Published On :: Wed, 06 May 2020 11:28:32 +0000 The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular death and hospitalisation in adult patients with New York Heart Association’s functional class II-IV heart failure with reduced ejection fraction. Full Article AstraZeneca farxiga FDA heart failure Research and Development Sales and Marketing
xi AstraZeneca and Saint Luke’s Mid America Heart Institute initiate Phase III DARE-19 trial with Farxiga in COVID-19 patients By www.pharmanews.eu Published On :: Fri, 24 Apr 2020 10:00:00 +0200 AstraZeneca and Saint Luke's Mid America Heart Institute have initiated a randomised, global Phase III trial to assess the potential of Farxiga (dapagliflozin) as a treatment in patients hospitalised with COVID-19 who are at risk of developing serious complications, such as organ failure. Full Article Featured AstraZeneca Business
xi Repurposing existing drugs for COVID-19 offers a more rapid alternative to a vaccine By www.pharmanews.eu Published On :: Thu, 07 May 2020 10:00:00 +0200 Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology today. Since the emergence of the SARS-CoV-2 virus in late 2019, more than 3.5 million people are known to have been infected, leading to over 240,000 deaths worldwide from COVID-19, the disease caused by the novel coronavirus. Full Article Featured Research Research & Development
xi Portola agrees to takeover bid from Alexion By www.thepharmaletter.com Published On :: Wed, 06 May 2020 12:26:00 +0100 Following a couple of active M&A years, USA-based Alexion Pharmaceuticals has now reached a definitive… Full Article Alexion Pharmaceuticals/AndexXa/Anticoagulants/Biotechnology/Cardio-vascular/Companies mergers and acquisitions/Hematology/Ondexxya/Portola Pharmaceuticals/USA
xi FDA approval for Farxiga in new indication in heart failure patients By www.thepharmaletter.com Published On :: Wed, 06 May 2020 14:59:00 +0100 Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and… Full Article AstraZeneca/Cardio-vascular/Diabetes/Farxiga/Focus On/Glucosides/Pharmaceutical/Regulation/SGLT2 inhibitors/UK/US FDA/USA
xi Alexion exceeds earnings estimates but drops guidance By www.thepharmaletter.com Published On :: Wed, 06 May 2020 15:22:00 +0100 US drugmaker Alexion Pharmaceuticals fared better in its revenue and adjusted earnings figures in the… Full Article Alexion Pharmaceuticals/Autoimmune Disorders/Biotechnology/Financial/Immunologicals/Management/Rare diseases/Soliris/Strensiq/Ultomiris/USA
xi Bausch Health and partners settle Xifaxan IP litigation By www.thepharmaletter.com Published On :: Wed, 06 May 2020 17:28:00 +0100 Canada-based Bausch Health Companies, along with its wholly-owned subsidiary, Salix Pharmaceuticals and… Full Article Alfasigma/Bausch Health Companies Inc./Canada/Deals/Legal/Licensing/Nephrology and Hepatology/Patents & Trademarks/Pharmaceutical/Salix Pharmaceuticals Ltd/Sandoz/Switzerland/USA/Xifaxan
xi AstraZeneca's Farxiga scores landmark FDA nod in heart failure patients with or without diabetes By www.fiercepharma.com Published On :: Wed, 06 May 2020 14:42:58 +0000 AstraZeneca has watched superstar SGLT2 diabetes med Farxiga nail trial after trial in highly coveted kidney and heart failure indications, with the FDA expediting reviews to back them up. The one thing AstraZeneca was missing? The agency taking Farxiga across the finish line. Full Article
xi LAN Cargo S.A., Aerolinhas Brasileiras S.A. and EL AL Israel Airlines Ltd. Agree to Plead Guilty for Fixing Prices on Air Cargo Shipments By www.justice.gov Published On :: Thu, 22 Jan 2009 11:57:56 EST Three air cargo carriers, LAN Cargo S.A. (LAN Cargo), Aerolinhas Brasileiras S.A. (ABSA), and EL AL Israel Airlines Ltd. (EL AL), have each agreed to plead guilty and pay criminal fines totaling $124.7 million for their roles in a conspiracy to fix prices in the air cargo industry. Full Article OPA Press Releases
xi Three Foreign Executives Indicted for Their Roles in LCD Price-Fixing Conspiracy By www.justice.gov Published On :: Tue, 3 Feb 2009 19:03:02 EST A federal grand jury in San Francisco returned an indictment against two former executives from Chunghwa Picture Tubes Ltd. (Chunghwa) and one former executive from LG Display Co. Ltd. (LG) for their participation in a global conspiracy to fix prices of Thin Film Transistor-Liquid Crystal Display (TFT-LCD) panels. Full Article OPA Press Releases
xi Former Executive Indicted for His Role in Two Cathode Ray Tube Price-Fixing Conspiracies By www.justice.gov Published On :: Tue, 10 Feb 2009 20:14:06 EST A federal grand jury in San Francisco today returned a two-count indictment against the former Chairman and Chief Executive Officer of Chunghwa Picture Tubes Ltd. for his participation in global conspiracies to fix prices of two types of cathode ray tubes (CRTs) used in computer monitors and televisions. Full Article OPA Press Releases
xi Former Cartel Leader Extradited from Mexico By www.justice.gov Published On :: Thu, 26 Feb 2009 19:58:42 EST Miguel Caro Quintero, the alleged former leader of the now-defunct Sonora Cartel, was extradited by the government of Mexico to the United States on Feb. 25, 2009. Miguel Caro Quintero arrived in the United States yesterday and has been transferred to the District of Colorado to face charges including racketeering and narcotics trafficking. Full Article OPA Press Releases
xi United States Joins Suit Against Community Health Systems Inc. and Three of Its Hospitals in New Mexico By www.justice.gov Published On :: Fri, 6 Mar 2009 16:10:04 EST The United States has intervened in a whistleblower suit filed in the District of New Mexico against Community Health Systems Inc. (CHS) and three of its hospitals in New Mexico: Eastern New Mexico Medical Center in Roswell, Mimbres Memorial Hospital in Deming, and Alta Vista Regional Hospital in Las Vegas. The suit alleges that CHS and its three hospitals violated the False Claims Act (FCA) by knowingly causing to be presented to the United States false claims for federal matching Medicaid funds. Full Article OPA Press Releases
xi Hitachi Displays Agrees to Plead Guilty and Pay $31 Million Fine for Participating in LCD Price-Fixing Conspiracy By www.justice.gov Published On :: Tue, 10 Mar 2009 13:02:09 EDT Japanese electronics manufacturer Hitachi Displays Ltd., agreed to plead guilty and pay a $31 million fine for its role in a conspiracy to fix prices in the sale of Thin Film Transistor-Liquid Crystal Display panels (TFT-LCD) sold to Dell Inc. Full Article OPA Press Releases
xi Hitachi Executive Indicted for His Role in LCD Price-Fixing Conspiracy By www.justice.gov Published On :: Tue, 31 Mar 2009 18:52:35 EDT A federal grand jury in San Francisco returned an indictment today charging an executive at Hitachi Displays Ltd. with participating in a global conspiracy to fix the prices of Thin Film Transistor-Liquid Crystal Display (TFT-LCD) panels sold to Dell Inc. Full Article OPA Press Releases
xi U.S. Sues 32 Individuals, Alleging $30 Million Tax Credit Scam Based on Sham Sales from Non-Existent Methane Production Facilities at Landfills By www.justice.gov Published On :: Thu, 2 Apr 2009 14:08:05 EDT The United States has sued four Certified Public Accounts (CPA), 27 tax preparers and one other individual, seeking to bar them from promoting an alleged tax scam involving bogus income tax credits claimed for sham sales of methane from landfills. Full Article OPA Press Releases
xi Fact Sheet: Department of Justice Efforts to Combat Mexican Drug Cartels By www.justice.gov Published On :: Thu, 2 Apr 2009 18:00:23 EDT The increased efforts and reallocation of personnel recently announced by the Department of Justice builds on the foundation of expertise and experience gained from ongoing efforts to combat Mexican drug cartels in the United States and to help Mexican law enforcement battle cartels in its own country. Full Article OPA Press Releases
xi Mexican Man Sentenced to 24 Years for Sex Trafficking of Minors and Transportation for the Purpose of Commercial Sex By www.justice.gov Published On :: Mon, 6 Apr 2009 18:15:55 EDT Jorge Flores-Rojas, 44, an undocumented Mexican national, was sentenced to 24 years in prison by Chief Judge Robert J. Conrad, Jr. in Charlotte, N.C., for two counts of sex trafficking of minors and one count of interstate transportation of an adult for purposes of commercial sex. Flores-Rojas pled guilty to the charges on Oct. 7, 2008. Full Article OPA Press Releases
xi Three International Airline Companies Agree to Plead Guilty to Price Fixing on Air Cargo Shipments By www.justice.gov Published On :: Thu, 9 Apr 2009 11:32:55 EDT Three international airline companiesLuxembourg-based Cargolux Airlines International S.A., Japan-based Nippon Cargo Airlines Co. Ltd. (NCA), and Korea-based Asiana Airlines Inc.have each agreed to plead guilty and pay criminal fines totaling $214 million for conspiring to fix prices in the air cargo industry. In addition, Asiana was charged with fixing the passenger fares charged on flights from the United States to Korea. Full Article OPA Press Releases
xi Korean Executive Agrees to Plead Guilty and Serve One Year in Prison for Participation in LCD Price-Fixing Conspiracy By www.justice.gov Published On :: Mon, 27 Apr 2009 13:27:02 EDT A high-level Korean executive from LG Display Co. Ltd. (LG) has agreed to plead guilty and serve a year in jail in the United States for participating in a global conspiracy to fix prices in the sale of Thin Film Transistor-Liquid Crystal Display (TFT-LCD) panels. Full Article OPA Press Releases
xi Dutch Airline Executive Agrees to Plead Guilty for Fixing Prices on Air Cargo Shipments By www.justice.gov Published On :: Wed, 29 Apr 2009 13:03:31 EDT A Dutch citizen and executive of Martinair Holland N.V. (Martinair) has agreed to plead guilty, serve time in jail and pay a criminal fine for participating in a conspiracy to fix cargo rates for international air shipments. Including todays charge, a total of 15 airlines and four executives have pleaded guilty or agreed to plead guilty in the Justice Departments ongoing investigation into price fixing in the air transportation industry. Full Article OPA Press Releases